Cargando…
Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627622/ https://www.ncbi.nlm.nih.gov/pubmed/37936678 http://dx.doi.org/10.1097/HS9.0000000000000975 |
| _version_ | 1785131561008496640 |
|---|---|
| author | Kastritis, Efstathios Theodorakakou, Foteini Stathopoulos, Ioannis-Ntanasis Spiliopoulou, Vassiliki Solia, Eirini Malandrakis, Panagiotis Syrigou, Rodanthi Kokkali, Nikoleta Migkou, Magdalini Eleutherakis-Papaiakovou, Evangelos Fotiou, Despina Roussou, Maria Kanellias, Nikolaos Gavriatopoulou, Maria Terpos, Evangelos Dimopoulos, Meletios A. |
| author_facet | Kastritis, Efstathios Theodorakakou, Foteini Stathopoulos, Ioannis-Ntanasis Spiliopoulou, Vassiliki Solia, Eirini Malandrakis, Panagiotis Syrigou, Rodanthi Kokkali, Nikoleta Migkou, Magdalini Eleutherakis-Papaiakovou, Evangelos Fotiou, Despina Roussou, Maria Kanellias, Nikolaos Gavriatopoulou, Maria Terpos, Evangelos Dimopoulos, Meletios A. |
| author_sort | Kastritis, Efstathios |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10627622 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106276222023-11-07 Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies Kastritis, Efstathios Theodorakakou, Foteini Stathopoulos, Ioannis-Ntanasis Spiliopoulou, Vassiliki Solia, Eirini Malandrakis, Panagiotis Syrigou, Rodanthi Kokkali, Nikoleta Migkou, Magdalini Eleutherakis-Papaiakovou, Evangelos Fotiou, Despina Roussou, Maria Kanellias, Nikolaos Gavriatopoulou, Maria Terpos, Evangelos Dimopoulos, Meletios A. Hemasphere Letter Lippincott Williams & Wilkins 2023-11-03 /pmc/articles/PMC10627622/ /pubmed/37936678 http://dx.doi.org/10.1097/HS9.0000000000000975 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Kastritis, Efstathios Theodorakakou, Foteini Stathopoulos, Ioannis-Ntanasis Spiliopoulou, Vassiliki Solia, Eirini Malandrakis, Panagiotis Syrigou, Rodanthi Kokkali, Nikoleta Migkou, Magdalini Eleutherakis-Papaiakovou, Evangelos Fotiou, Despina Roussou, Maria Kanellias, Nikolaos Gavriatopoulou, Maria Terpos, Evangelos Dimopoulos, Meletios A. Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies |
| title | Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies |
| title_full | Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies |
| title_fullStr | Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies |
| title_full_unstemmed | Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies |
| title_short | Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies |
| title_sort | management and outcomes of anti-cd38 refractory patients: the impact of retreatment and of subsequent therapies |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627622/ https://www.ncbi.nlm.nih.gov/pubmed/37936678 http://dx.doi.org/10.1097/HS9.0000000000000975 |
| work_keys_str_mv | AT kastritisefstathios managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT theodorakakoufoteini managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT stathopoulosioannisntanasis managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT spiliopoulouvassiliki managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT soliaeirini managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT malandrakispanagiotis managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT syrigourodanthi managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT kokkalinikoleta managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT migkoumagdalini managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT eleutherakispapaiakovouevangelos managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT fotioudespina managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT roussoumaria managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT kanelliasnikolaos managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT gavriatopouloumaria managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT terposevangelos managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies AT dimopoulosmeletiosa managementandoutcomesofanticd38refractorypatientstheimpactofretreatmentandofsubsequenttherapies |